ID   PYRG2_HUMAN             Reviewed;         586 AA.
AC   Q9NRF8; B3KWM2; Q9BRI0; Q9H809; Q9H8K9;
DT   25-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   12-APR-2017, entry version 143.
DE   RecName: Full=CTP synthase 2;
DE            EC=6.3.4.2;
DE   AltName: Full=CTP synthetase 2;
DE   AltName: Full=UTP--ammonia ligase 2;
GN   Name=CTPS2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RX   PubMed=10899599; DOI=10.1016/S0167-4781(00)00141-X;
RA   van Kuilenburg A.B.P., Meinsma R., Vreken P., Waterham H.R.,
RA   van Gennip A.H.;
RT   "Identification of a cDNA encoding an isoform of human CTP
RT   synthetase.";
RL   Biochim. Biophys. Acta 1492:548-552(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta, and Retinoblastoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION.
RX   PubMed=16179339; DOI=10.1074/jbc.M509622200;
RA   Han G.-S., Sreenivas A., Choi M.-G., Chang Y.-F., Martin S.S.,
RA   Baldwin E.P., Carman G.M.;
RT   "Expression of human CTP synthetase in Saccharomyces cerevisiae
RT   reveals phosphorylation by protein kinase A.";
RL   J. Biol. Chem. 280:38328-38336(2005).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-571, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-568; SER-571 AND
RP   SER-574, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-568; SER-571 AND
RP   SER-574, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-568 AND SER-571, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-568; SER-571 AND
RP   SER-574, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-568; SER-571 AND
RP   SER-574, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Catalyzes the ATP-dependent amination of UTP to CTP with
CC       either L-glutamine or ammonia as the source of nitrogen.
CC       Constitutes the rate-limiting enzyme in the synthesis of cytosine
CC       nucleotides. {ECO:0000269|PubMed:10899599,
CC       ECO:0000269|PubMed:16179339}.
CC   -!- CATALYTIC ACTIVITY: ATP + UTP + L-glutamine = ADP + phosphate +
CC       CTP + L-glutamate.
CC   -!- PATHWAY: Pyrimidine metabolism; CTP biosynthesis via de novo
CC       pathway; CTP from UDP: step 2/2.
CC   -!- INTERACTION:
CC       Q9NZD8:SPG21; NbExp=4; IntAct=EBI-740874, EBI-742688;
CC   -!- SIMILARITY: Belongs to the CTP synthase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF226667; AAF91241.1; -; mRNA.
DR   EMBL; AK023549; BAB14607.1; -; mRNA.
DR   EMBL; AK024070; BAB14814.1; -; mRNA.
DR   EMBL; AK125332; BAG54184.1; -; mRNA.
DR   EMBL; AK125348; BAG54188.1; -; mRNA.
DR   EMBL; AL445467; CAI40086.1; -; Genomic_DNA.
DR   EMBL; AC073909; CAI40086.1; JOINED; Genomic_DNA.
DR   EMBL; CH471074; EAW98912.1; -; Genomic_DNA.
DR   EMBL; BC006256; AAH06256.2; -; mRNA.
DR   EMBL; BC034986; AAH34986.1; -; mRNA.
DR   CCDS; CCDS14175.1; -.
DR   RefSeq; NP_001137474.1; NM_001144002.1.
DR   RefSeq; NP_062831.3; NM_019857.4.
DR   RefSeq; NP_787055.1; NM_175859.2.
DR   RefSeq; XP_005274619.1; XM_005274562.3.
DR   RefSeq; XP_006724566.1; XM_006724503.3.
DR   UniGene; Hs.227049; -.
DR   PDB; 2V4U; X-ray; 2.30 A; A=297-562.
DR   PDB; 2VKT; X-ray; 2.50 A; A=297-562.
DR   PDB; 3IHL; X-ray; 2.80 A; A/B=1-275.
DR   PDBsum; 2V4U; -.
DR   PDBsum; 2VKT; -.
DR   PDBsum; 3IHL; -.
DR   ProteinModelPortal; Q9NRF8; -.
DR   SMR; Q9NRF8; -.
DR   BioGrid; 121144; 31.
DR   IntAct; Q9NRF8; 11.
DR   MINT; MINT-1443035; -.
DR   STRING; 9606.ENSP00000352222; -.
DR   MEROPS; C26.A36; -.
DR   iPTMnet; Q9NRF8; -.
DR   PhosphoSitePlus; Q9NRF8; -.
DR   BioMuta; CTPS2; -.
DR   DMDM; 74752919; -.
DR   EPD; Q9NRF8; -.
DR   MaxQB; Q9NRF8; -.
DR   PaxDb; Q9NRF8; -.
DR   PeptideAtlas; Q9NRF8; -.
DR   PRIDE; Q9NRF8; -.
DR   DNASU; 56474; -.
DR   Ensembl; ENST00000359276; ENSP00000352222; ENSG00000047230.
DR   Ensembl; ENST00000380241; ENSP00000369590; ENSG00000047230.
DR   Ensembl; ENST00000443824; ENSP00000401264; ENSG00000047230.
DR   GeneID; 56474; -.
DR   KEGG; hsa:56474; -.
DR   UCSC; uc004cxk.4; human.
DR   CTD; 56474; -.
DR   GeneCards; CTPS2; -.
DR   HGNC; HGNC:2520; CTPS2.
DR   HPA; HPA017437; -.
DR   MIM; 300380; gene.
DR   neXtProt; NX_Q9NRF8; -.
DR   OpenTargets; ENSG00000047230; -.
DR   PharmGKB; PA27021; -.
DR   eggNOG; KOG2387; Eukaryota.
DR   eggNOG; COG0504; LUCA.
DR   GeneTree; ENSGT00390000012473; -.
DR   HOGENOM; HOG000077514; -.
DR   HOVERGEN; HBG002243; -.
DR   InParanoid; Q9NRF8; -.
DR   KO; K01937; -.
DR   OMA; FEVNPNL; -.
DR   OrthoDB; EOG091G03OK; -.
DR   PhylomeDB; Q9NRF8; -.
DR   TreeFam; TF300379; -.
DR   BioCyc; MetaCyc:HS00585-MONOMER; -.
DR   BRENDA; 6.3.4.2; 2681.
DR   Reactome; R-HSA-499943; Synthesis and interconversion of nucleotide di- and triphosphates.
DR   SIGNOR; Q9NRF8; -.
DR   UniPathway; UPA00159; UER00277.
DR   ChiTaRS; CTPS2; human.
DR   EvolutionaryTrace; Q9NRF8; -.
DR   GeneWiki; CTPS2; -.
DR   GenomeRNAi; 56474; -.
DR   PRO; PR:Q9NRF8; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000047230; -.
DR   CleanEx; HS_CTPS2; -.
DR   ExpressionAtlas; Q9NRF8; baseline and differential.
DR   Genevisible; Q9NRF8; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003883; F:CTP synthase activity; EXP:Reactome.
DR   GO; GO:0044210; P:'de novo' CTP biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0006541; P:glutamine metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0015949; P:nucleobase-containing small molecule interconversion; TAS:Reactome.
DR   GO; GO:0006220; P:pyrimidine nucleotide metabolic process; TAS:ProtInc.
DR   CDD; cd01746; GATase1_CTP_Synthase; 1.
DR   Gene3D; 3.40.50.880; -; 1.
DR   InterPro; IPR029062; Class_I_gatase-like.
DR   InterPro; IPR004468; CTP_synthase.
DR   InterPro; IPR017456; CTP_synthase_N.
DR   InterPro; IPR017926; GATASE.
DR   InterPro; IPR033828; GATase1_CTP_Synthase.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR11550; PTHR11550; 1.
DR   Pfam; PF06418; CTP_synth_N; 1.
DR   Pfam; PF00117; GATase; 1.
DR   SUPFAM; SSF52317; SSF52317; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   TIGRFAMs; TIGR00337; PyrG; 1.
DR   PROSITE; PS51273; GATASE_TYPE_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome;
KW   Glutamine amidotransferase; Ligase; Nucleotide-binding;
KW   Phosphoprotein; Pyrimidine biosynthesis; Reference proteome.
FT   CHAIN         1    586       CTP synthase 2.
FT                                /FTId=PRO_0000247033.
FT   DOMAIN      300    554       Glutamine amidotransferase type-1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00605}.
FT   ACT_SITE    399    399       For GATase activity.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00605}.
FT   ACT_SITE    526    526       For GATase activity.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00605}.
FT   ACT_SITE    528    528       For GATase activity.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00605}.
FT   MOD_RES     568    568       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     571    571       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     574    574       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   CONFLICT    220    220       T -> S (in Ref. 2; BAB14814).
FT                                {ECO:0000305}.
FT   CONFLICT    233    233       F -> L (in Ref. 2; BAB14607).
FT                                {ECO:0000305}.
FT   CONFLICT    304    304       V -> A (in Ref. 2; BAB14607).
FT                                {ECO:0000305}.
FT   STRAND        2      8       {ECO:0000244|PDB:3IHL}.
FT   STRAND       10     15       {ECO:0000244|PDB:3IHL}.
FT   HELIX        16     28       {ECO:0000244|PDB:3IHL}.
FT   TURN         29     31       {ECO:0000244|PDB:3IHL}.
FT   STRAND       34     40       {ECO:0000244|PDB:3IHL}.
FT   STRAND       48     50       {ECO:0000244|PDB:3IHL}.
FT   STRAND       58     60       {ECO:0000244|PDB:3IHL}.
FT   STRAND       87     89       {ECO:0000244|PDB:3IHL}.
FT   HELIX        90    102       {ECO:0000244|PDB:3IHL}.
FT   TURN        103    108       {ECO:0000244|PDB:3IHL}.
FT   HELIX       113    129       {ECO:0000244|PDB:3IHL}.
FT   STRAND      141    147       {ECO:0000244|PDB:3IHL}.
FT   HELIX       154    156       {ECO:0000244|PDB:3IHL}.
FT   HELIX       157    169       {ECO:0000244|PDB:3IHL}.
FT   HELIX       172    174       {ECO:0000244|PDB:3IHL}.
FT   STRAND      175    182       {ECO:0000244|PDB:3IHL}.
FT   TURN        187    189       {ECO:0000244|PDB:3IHL}.
FT   HELIX       195    206       {ECO:0000244|PDB:3IHL}.
FT   STRAND      212    220       {ECO:0000244|PDB:3IHL}.
FT   HELIX       224    233       {ECO:0000244|PDB:3IHL}.
FT   HELIX       238    240       {ECO:0000244|PDB:3IHL}.
FT   STRAND      241    245       {ECO:0000244|PDB:3IHL}.
FT   HELIX       252    259       {ECO:0000244|PDB:3IHL}.
FT   HELIX       262    270       {ECO:0000244|PDB:3IHL}.
FT   STRAND      297    306       {ECO:0000244|PDB:2V4U}.
FT   HELIX       312    314       {ECO:0000244|PDB:2V4U}.
FT   HELIX       315    327       {ECO:0000244|PDB:2V4U}.
FT   STRAND      330    338       {ECO:0000244|PDB:2V4U}.
FT   HELIX       339    342       {ECO:0000244|PDB:2V4U}.
FT   HELIX       344    349       {ECO:0000244|PDB:2V4U}.
FT   HELIX       351    363       {ECO:0000244|PDB:2V4U}.
FT   STRAND      365    369       {ECO:0000244|PDB:2V4U}.
FT   HELIX       378    390       {ECO:0000244|PDB:2V4U}.
FT   STRAND      395    398       {ECO:0000244|PDB:2V4U}.
FT   HELIX       400    413       {ECO:0000244|PDB:2V4U}.
FT   STRAND      419    422       {ECO:0000244|PDB:2V4U}.
FT   STRAND      429    435       {ECO:0000244|PDB:2V4U}.
FT   STRAND      449    458       {ECO:0000244|PDB:2V4U}.
FT   HELIX       463    467       {ECO:0000244|PDB:2V4U}.
FT   STRAND      472    480       {ECO:0000244|PDB:2V4U}.
FT   STRAND      482    484       {ECO:0000244|PDB:2V4U}.
FT   HELIX       486    488       {ECO:0000244|PDB:2V4U}.
FT   HELIX       490    492       {ECO:0000244|PDB:2V4U}.
FT   STRAND      495    503       {ECO:0000244|PDB:2V4U}.
FT   STRAND      508    518       {ECO:0000244|PDB:2V4U}.
FT   STRAND      520    526       {ECO:0000244|PDB:2V4U}.
FT   HELIX       527    530       {ECO:0000244|PDB:2V4U}.
FT   HELIX       538    548       {ECO:0000244|PDB:2V4U}.
FT   HELIX       551    556       {ECO:0000244|PDB:2V4U}.
SQ   SEQUENCE   586 AA;  65678 MW;  AC1CF2E67D89741B CRC64;
     MKYILVTGGV ISGIGKGIIA SSIGTILKSC GLRVTAIKID PYINIDAGTF SPYEHGEVFV
     LNDGGEVDLD LGNYERFLDI NLYKDNNITT GKIYQHVINK ERRGDYLGKT VQVVPHITDA
     VQEWVMNQAK VPVDGNKEEP QICVIELGGT IGDIEGMPFV EAFRQFQFKA KRENFCNIHV
     SLVPQLSATG EQKTKPTQNS VRALRGLGLS PDLIVCRSST PIEMAVKEKI SMFCHVNPEQ
     VICIHDVSST YRVPVLLEEQ SIVKYFKERL HLPIGDSASN LLFKWRNMAD RYERLQKICS
     IALVGKYTKL RDCYASVFKA LEHSALAINH KLNLMYIDSI DLEKITETED PVKFHEAWQK
     LCKADGILVP GGFGIRGTLG KLQAISWART KKIPFLGVCL GMQLAVIEFA RNCLNLKDAD
     STEFRPNAPV PLVIDMPEHN PGNLGGTMRL GIRRTVFKTE NSILRKLYGD VPFIEERHRH
     RFEVNPNLIK QFEQNDLSFV GQDVDGDRME IIELANHPYF VGVQFHPEFS SRPMKPSPPY
     LGLLLAATGN LNAYLQQGCK LSSSDRYSDA SDDSFSEPRI AELEIS
//
